Description

Pathway enrichment analysis of metabolites altered by dexamethasone treatment across multiple tissue types. The metabolomic profiling reveals affected biochemical pathways relevant to glucocorticoid side effects.

Figure 13

Chart

Source Paper

Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical Isotope Labeling LC-MS analysis.

Metabolites (2020)

PMID: 31973046

DOI: 10.3390/metabo10020042

Cite This Figure

![Figure 13: Pathway enrichment analysis of metabolites altered by dexamethasone treatment across multiple tissue types. The metabolomic profiling reveals affected biochemical pathways relevant to glucocorticoid side effects.]()

> Source: Lina A Dahabiyeh et al. "Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical ." *Metabolites*, 2020. PMID: [31973046](https://pubmed.ncbi.nlm.nih.gov/31973046/)

<figure>
  <img src="" alt="Pathway enrichment analysis of metabolites altered by dexamethasone treatment across multiple tissue types. The metabolomic profiling reveals affected biochemical pathways relevant to glucocorticoid side effects." />
  <figcaption>Figure 13. Pathway enrichment analysis of metabolites altered by dexamethasone treatment across multiple tissue types. The metabolomic profiling reveals affected biochemical pathways relevant to glucocorticoid side effects.<br>  Source: Lina A Dahabiyeh et al. "Dexamethasone-Induced Perturbations in Tissue Metabolomics Revealed by Chemical ." <em>Metabolites</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31973046/">31973046</a></figcaption>
</figure>

Related Evidence

Uridine Monophosphate for Neurotransmitter Imbalance

Grade C · 4 studies